company background image
2INV logo

2invest XTRA:2INV Stock Report

Last Price

€8.50

Market Cap

€48.9m

7D

-2.3%

1Y

29.8%

Updated

09 May, 2024

Data

Company Financials

2INV Stock Overview

2invest AG, an investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.

2INV fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

2invest AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for 2invest
Historical stock prices
Current Share Price€8.50
52 Week High€8.80
52 Week Low€5.55
Beta0.26
1 Month Change-1.16%
3 Month Change6.92%
1 Year Change29.77%
3 Year Change-25.96%
5 Year Change2.88%
Change since IPO-75.49%

Recent News & Updates

We Think 2invest's (ETR:2INV) Robust Earnings Are Conservative

May 01
We Think 2invest's (ETR:2INV) Robust Earnings Are Conservative

Recent updates

We Think 2invest's (ETR:2INV) Robust Earnings Are Conservative

May 01
We Think 2invest's (ETR:2INV) Robust Earnings Are Conservative

Shareholder Returns

2INVDE BiotechsDE Market
7D-2.3%-0.7%2.5%
1Y29.8%-21.2%5.4%

Return vs Industry: 2INV exceeded the German Biotechs industry which returned -23.6% over the past year.

Return vs Market: 2INV exceeded the German Market which returned 4.6% over the past year.

Price Volatility

Is 2INV's price volatile compared to industry and market?
2INV volatility
2INV Average Weekly Movement2.2%
Biotechs Industry Average Movement5.3%
Market Average Movement5.0%
10% most volatile stocks in DE Market10.5%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 2INV has not had significant price volatility in the past 3 months.

Volatility Over Time: 2INV's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a5n/a2invest-ag.com

2invest AG, an investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally. The company was formerly known as 4basebio AG and changed its name to 2invest AG in January 2021. 2invest AG is based in Heidelberg, Germany.

2invest AG Fundamentals Summary

How do 2invest's earnings and revenue compare to its market cap?
2INV fundamental statistics
Market cap€48.86m
Earnings (TTM)€1.58m
Revenue (TTM)€9.00m

31.0x

P/E Ratio

5.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2INV income statement (TTM)
Revenue€9.00m
Cost of Revenue€0
Gross Profit€9.00m
Other Expenses€7.43m
Earnings€1.58m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.27
Gross Margin100.00%
Net Profit Margin17.51%
Debt/Equity Ratio0%

How did 2INV perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.